Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators Register
JAMA Dermatol, 2020.
Yiu ZZN, Mason KJ, Hampton PJ, Reynolds NJ, Smith CH, Lunt M, Griffiths CEM, Warren RB; BADBIR Study Group.
Read publication: JAMA Dermatol
Related
Characteristics of "super responders" and "super nonresponders" to first biologic monotherapy for ps...
Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR
Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic ...
0 Comments